METASTATIC SQUAMOUS CELL CARCINOMA
Clinical trials for METASTATIC SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weekly combo aims to control aggressive Head/Neck cancer
Disease control Recruiting nowThis study is testing a weekly combination of chemotherapy and immunotherapy for people with advanced head and neck cancer that has spread and who cannot take a standard chemotherapy drug called 5-FU. The goal is to see if this weekly schedule helps shrink tumors and control the …
Matched conditions: METASTATIC SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New Triple-Threat attack on tough head and neck cancers
Disease control Recruiting nowThis early-stage study is testing a new combination of three drugs for people with advanced head and neck cancer that has returned or spread. The main goal is to find the safest and most effective dose of the new drug, Zanzalintinib, when given with two existing cancer drugs. Res…
Matched conditions: METASTATIC SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 03, 2026 14:06 UTC